Hydroxyprostaglandin Dehydrogenases
"Hydroxyprostaglandin Dehydrogenases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Catalyzes reversibly the oxidation of hydroxyl groups of prostaglandins.
| Descriptor ID |
D006911
|
| MeSH Number(s) |
D08.811.682.047.820.375
|
| Concept/Terms |
Hydroxyprostaglandin Dehydrogenases- Hydroxyprostaglandin Dehydrogenases
- Dehydrogenases, Hydroxyprostaglandin
- Hydroxyprostaglandin Dehydrogenase
- Dehydrogenase, Hydroxyprostaglandin
- Prostacyclin Dehydrogenase
- Dehydrogenase, Prostacyclin
|
Below are MeSH descriptors whose meaning is more general than "Hydroxyprostaglandin Dehydrogenases".
Below are MeSH descriptors whose meaning is more specific than "Hydroxyprostaglandin Dehydrogenases".
This graph shows the total number of publications written about "Hydroxyprostaglandin Dehydrogenases" by people in this website by year, and whether "Hydroxyprostaglandin Dehydrogenases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hydroxyprostaglandin Dehydrogenases" by people in Profiles.
-
A novel fluorometric assay for aldo-keto reductase 1C3 predicts metabolic activation of the nitrogen mustard prodrug PR-104A in human leukaemia cells. Biochem Pharmacol. 2014 Mar 01; 88(1):36-45.
-
Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors. Cancer Res. 2012 Dec 01; 72(23):6142-52.
-
Pioglitazone, a PPAR? agonist, suppresses CYP19 transcription: evidence for involvement of 15-hydroxyprostaglandin dehydrogenase and BRCA1. Cancer Prev Res (Phila). 2012 Oct; 5(10):1183-94.
-
Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression. Am J Pathol. 2010 Mar; 176(3):1462-8.
-
Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes. Am J Physiol Gastrointest Liver Physiol. 2009 Sep; 297(3):G559-66.
-
15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors. Proc Natl Acad Sci U S A. 2009 Jun 09; 106(23):9409-13.
-
NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer. Cancer Prev Res (Phila). 2008 Sep; 1(4):241-9.
-
Structural and mutational analysis of Trypanosoma brucei prostaglandin H2 reductase provides insight into the catalytic mechanism of aldo-ketoreductases. J Biol Chem. 2005 Jul 15; 280(28):26371-82.
-
Preferential expression of hPGFS in primary SCCHN and tumour cell lines derived from respiratory and digestive organs. Br J Cancer. 2004 Mar 08; 90(5):1093-9.
-
Expression of key prostaglandin synthases in equine endometrium during late diestrus and early pregnancy. Biol Reprod. 2004 Feb; 70(2):391-9.